Gengos Andrew
SEC insider (Form 3/4/5 filer). CIK 0001563623. Chief Financial Officer at Immuneering Corp (IMRX) and 3 other issuers. 15 reported Form 4/5 transactions since Sep 2024; latest on Jul 16, 2026. Located in CAMBRIDGE, MA.
Companies Gengos Andrew has filed insider reports for
- Immuneering Corp (IMRX): Officer, Chief Financial Officer
- Turn Therapeutics Inc. (TTRX): Director
- Terns Pharmaceuticals, Inc. (TERN): Officer, Chief Financial Officer
- Athira Pharma, Inc. (ATHA): Officer, CFO and Chief Business Officer
Gengos Andrew
CIK: 0001563623
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (15 total)
- Jul 16, 2026IMRX
Immuneering Corp
AwardDirectStock Option
650K shares- - Jun 4, 2026TTRX
Turn Therapeutics Inc.
AwardDirectStock option (right to buy)
95K shares- - May 5, 2026TERN
Terns Pharmaceuticals, Inc.
DispositionDirect68.8K shares at avg. $53.00$3.6M - May 5, 2026TERN
Terns Pharmaceuticals, Inc.
Tender OfferDirect40.5K shares at avg. $53.00$2.1M - Jan 14, 2026TERN
Terns Pharmaceuticals, Inc.
AwardDirect68.8K shares- - Oct 8, 2025TTRX
Turn Therapeutics Inc.
AwardDirect10K shares- - Jun 27, 2025TERN
Terns Pharmaceuticals, Inc.
PurchaseDirect5K shares at avg. $3.93$20K - Jun 27, 2025TERN
Terns Pharmaceuticals, Inc.
PurchaseDirect5K shares at avg. $3.93$20K - Jun 16, 2025TERN
Terns Pharmaceuticals, Inc.
PurchaseDirect5K shares at avg. $3.95$20K - Jun 13, 2025TERN
Terns Pharmaceuticals, Inc.
PurchaseDirect5K shares at avg. $3.72$19K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 16, 2026 |  IMRX Immuneering Corp | Award Stock Option | 650,000 | - | - | Direct |
| Jun 4, 2026 |  TTRX Turn Therapeutics Inc. | Award Stock option (right to buy) | 95,000 | - | - | Direct |
| May 5, 2026 |  TERN Terns Pharmaceuticals, Inc. | Disposition | 68,750 | $53.00 | $3,643,750 | Direct |
| May 5, 2026 | TERN Terns Pharmaceuticals, Inc. | Tender Offer | 40,503 | $53.00 | $2,146,659 | Direct |
| Jan 14, 2026 | TERN Terns Pharmaceuticals, Inc. | Award | 68,750 | - | $0 | Direct |
| Oct 8, 2025 | TTRX Turn Therapeutics Inc. | Award | 10,000 | - | - | Direct |
| Jun 27, 2025 | TERN Terns Pharmaceuticals, Inc. | Purchase | 5,000 | $3.93 | $19,634 | Direct |
| Jun 27, 2025 | TERN Terns Pharmaceuticals, Inc. | Purchase | 5,000 | $3.93 | $19,650 | Direct |
| Jun 16, 2025 | TERN Terns Pharmaceuticals, Inc. | Purchase | 5,000 | $3.95 | $19,733 | Direct |
| Jun 13, 2025 | TERN Terns Pharmaceuticals, Inc. | Purchase | 5,000 | $3.72 | $18,600 | Direct |
1-10 of 15 transactions